Capital Ii Ventech - Net Worth and Insider Trading
Capital Ii Ventech Net Worth
The estimated net worth of Capital Ii Ventech is at least $973 dollars as of 2024-09-21. Capital Ii Ventech is the 10% Owner of Kiora Pharmaceuticals Inc and owns about 265 shares of Kiora Pharmaceuticals Inc (KPRX) stock worth over $973. Details can be seen in Capital Ii Ventech's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Capital Ii Ventech has not made any transactions after 2017-03-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Capital Ii Ventech
Capital Ii Ventech Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Capital Ii Ventech owns 2 companies in total, including Kiora Pharmaceuticals Inc (KPRX) , and SCYNEXIS Inc (SCYX) .
Click here to see the complete history of Capital Ii Ventech’s form 4 insider trades.
Insider Ownership Summary of Capital Ii Ventech
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KPRX | Kiora Pharmaceuticals Inc | 2017-03-13 | 10 percent owner |
| SCYX | SCYNEXIS Inc | 2014-05-02 | 10 percent owner |
Capital Ii Ventech Latest Holdings Summary
Capital Ii Ventech currently owns a total of 1 stock. Capital Ii Ventech owns 265 shares of Kiora Pharmaceuticals Inc (KPRX) as of March 13, 2017, with a value of $973.
Latest Holdings of Capital Ii Ventech
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| KPRX | Kiora Pharmaceuticals Inc | 2017-03-13 | 265 | 3.67 | 973 |
Holding Weightings of Capital Ii Ventech
Capital Ii Ventech Form 4 Trading Tracker
According to the SEC Form 4 filings, Capital Ii Ventech has made a total of 0 transactions in Kiora Pharmaceuticals Inc (KPRX) over the past 5 years. The most-recent trade in Kiora Pharmaceuticals Inc is the sale of 1 shares on March 13, 2017, which brought Capital Ii Ventech around $12,373.
Insider Trading History of Capital Ii Ventech
- 1
Capital Ii Ventech Trading Performance
Capital Ii Ventech Ownership Network
Capital Ii Ventech Owned Company Details
What does Kiora Pharmaceuticals Inc do?
Who are the key executives at Kiora Pharmaceuticals Inc?
Capital Ii Ventech is the 10 percent owner of Kiora Pharmaceuticals Inc. Other key executives at Kiora Pharmaceuticals Inc include EVP of Finance Melissa Tosca , Chief Development Officer Eric Joseph Daniels , and director & President and CEO Brian M. Strem .
Kiora Pharmaceuticals Inc (KPRX) Insider Trades Summary
Over the past 18 months, Capital Ii Ventech made no insider transaction in Kiora Pharmaceuticals Inc (KPRX). Other recent insider transactions involving Kiora Pharmaceuticals Inc (KPRX) include a net purchase of 2,100 shares made by Melissa Tosca , a net purchase of 5,260 shares made by Erin Parsons , and a net purchase of 5,000 shares made by Praveen Tyle .
In summary, during the past 3 months, insiders sold 0 shares of Kiora Pharmaceuticals Inc (KPRX) in total and bought 12,500 shares, with a net purchase of 12,500 shares. During the past 18 months, 0 shares of Kiora Pharmaceuticals Inc (KPRX) were sold and 22,291 shares were bought by its insiders, resulting in a net purchase of 22,291 shares.
Kiora Pharmaceuticals Inc (KPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kiora Pharmaceuticals Inc Insider Transactions
Capital Ii Ventech Mailing Address
Above is the net worth, insider trading, and ownership report for Capital Ii Ventech. You might contact Capital Ii Ventech via mailing address: 47 Avenue De L?opera, Paris I0 75002.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
